Page last updated: 2024-08-24

emtricitabine and Sexually Transmitted Diseases

emtricitabine has been researched along with Sexually Transmitted Diseases in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's4 (57.14)2.80

Authors

AuthorsStudies
Barbosa, AKP; Batista, JDL; Montarroyos, UR; Monteiro, P; Montenegro, D1
Ando, N; Aoki, T; Ishizuka, N; Mizushima, D; Oka, S; Takano, M; Uemura, H; Watanabe, K; Yanagawa, Y1
Donald, JL; Gift, TL; Salas, SB; Schmidt, MA; Tao, G1
Amin, J; Bavinton, B; Cabrera Quichua, G; Grulich, AE; Guy, R; Holden, J; Jin, F; McManus, H; McNulty, A; Ogilvie, E; Price, K; Selvey, C; Smith, D; Vaccher, S; Vickers, T; Yeung, B; Zablotska, I1
Armishaw, J; Asselin, J; Batrouney, C; Chang, CC; Cornelisse, VJ; Cundill, P; El-Hayek, C; Fairley, CK; Forgan-Smith, G; Gall, J; Hellard, ME; Hoy, JF; Lal, L; Lockwood, JT; Mak, A; Murphy, DA; Nguyen, L; Penn, M; Pickett, C; Price, B; Roth, NJ; Ruth, S; Ryan, KE; Spelman, TD; Stoové, MA; Tee, BK; Traeger, MW; Vujovic, O; West, M; Willcox, J; Wright, EJ1
Buchbinder, SP; Glidden, DV; Goicochea, P; Grant, RM; Guanira, JV; Liu, AY; Mayer, KH; McMahan, V1
Aboulker, JP; Capitant, C; Charbonneau, P; Charreau, I; Chas, J; Cheret, A; Chidiac, C; Cotte, L; Cua, E; Delaugerre, C; Delfraissy, JF; Doré, V; Etien, N; Fonsart, J; Girard, G; Le Gall, JM; Lorente, N; Loze, B; Marchand, L; Meyer, L; Molina, JM; Pasquet, A; Peytavin, G; Pialoux, G; Pintado, C; Préau, M; Raffi, F; Rooney, JF; Rozenbaum, W; Simon, MC; Spire, B; Suzan-Monti, M; Thompson, D; Timsit, J; Tremblay, C; Wainberg, MA1

Trials

2 trial(s) available for emtricitabine and Sexually Transmitted Diseases

ArticleYear
HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.
    The Lancet. Infectious diseases, 2014, Volume: 14, Issue:6

    Topics: Adenine; Adolescent; Adult; Antiviral Agents; Condoms; Deoxycytidine; Emtricitabine; Female; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Male; Phosphorous Acids; Sexual Partners; Sexually Transmitted Diseases; South Africa; South America; Thailand; Transgender Persons; United States; Young Adult

2014
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
    The New England journal of medicine, 2015, Dec-03, Volume: 373, Issue:23

    Topics: Adult; Condoms; Double-Blind Method; Drug Therapy, Combination; Emtricitabine; HIV Infections; HIV-1; Homosexuality, Male; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Pre-Exposure Prophylaxis; Risk Factors; Sexual Behavior; Sexually Transmitted Diseases; Tenofovir

2015

Other Studies

5 other study(ies) available for emtricitabine and Sexually Transmitted Diseases

ArticleYear
HIV Pre-Exposure Prophylaxis (PrEP) in a Brazilian Clinical Setting: Adherence, Adverse Events, Sexual Behavior, and Sexually Transmitted Infections.
    Archives of sexual behavior, 2022, Volume: 51, Issue:5

    Topics: Anti-HIV Agents; Brazil; Emtricitabine; HIV Infections; Homosexuality, Male; Humans; Male; Pre-Exposure Prophylaxis; Prospective Studies; Sexual Behavior; Sexually Transmitted Diseases

2022
A four-year observation of HIV and sexually transmitted infections among men who have sex with men before and during pre-exposure prophylaxis in Tokyo.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:6

    Topics: Adult; Anti-HIV Agents; Emtricitabine; Female; HIV Infections; Homosexuality, Male; Humans; Male; Medication Adherence; Pre-Exposure Prophylaxis; Sexual and Gender Minorities; Sexually Transmitted Diseases; Tokyo

2022
Impact of the Early COVID-19 Pandemic on the Number of HIV Preexposure Prophylaxis Uses and the Proportion of Preexposure Prophylaxis Users Receiving Sexually Transmitted Infection Testing Services.
    Sexually transmitted diseases, 2023, 05-01, Volume: 50, Issue:5

    Topics: COVID-19; Emtricitabine; Gonorrhea; HIV Infections; Homosexuality, Male; Humans; Male; Pandemics; Pre-Exposure Prophylaxis; Retrospective Studies; Sexually Transmitted Diseases; Tenofovir

2023
Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men.
    JAMA network open, 2020, 12-01, Volume: 3, Issue:12

    Topics: Adult; Anti-HIV Agents; Australia; Cohort Studies; Emtricitabine; Health Risk Behaviors; HIV Infections; Humans; Incidence; Male; Pre-Exposure Prophylaxis; Sexual and Gender Minorities; Sexual Behavior; Sexually Transmitted Diseases; Tenofovir

2020
Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    JAMA, 2019, 04-09, Volume: 321, Issue:14

    Topics: Adolescent; Adult; Anti-HIV Agents; Australia; Bisexuality; Drug Therapy, Combination; Emtricitabine; HIV Infections; Homosexuality, Male; Humans; Incidence; Male; Middle Aged; Population Surveillance; Pre-Exposure Prophylaxis; Proportional Hazards Models; Sexually Transmitted Diseases; Tenofovir; Unsafe Sex; Young Adult

2019